Study (year) | LRNU route | Management of distal ureter # | Lymphadenectomy (%) (ORNU/LRNU) | Pathological stage ≥ pT3 (%) (ORNU/LRNU) | Pathological grade (%) (ORNU/LRNU) | Positive nodal status (%) (ORNU/LRNU) | Concomitant CIS (%) (ORNU/LRNU) | Present LVI (%) (ORNU/LRNU) | Positive surgical margins (%) (ORNU/LRNU) | NAC (%) (ORNU/LRNU) | AC (%) (ORNU/LRNU) |
---|---|---|---|---|---|---|---|---|---|---|---|
Ariane et al. (2012) [11] | TP | Mixed | Regional Selectively performed | pT3: 33.3/35.3 pT4: 6.3/1.3 | G1: 8.5/7.3 G2: 36.2/27.3 G3: 55.3/65.3 | 10.2/4.7* | NR | 19.2/18.7 | NR | Excluded | NR |
Azawi et al. (2020) [12] | NR | NR | Extent not described Whole cohort: 5% | pT3: 14.6/11.9 pT4: 5.6/1.7 | Low grade: 46.4/24.8* High grade: 53.6/75.2 | Whole cohort: 1.4% | NR | NR | NR | NR | NR |
Capitanio et al. (2009) [13] | NR | Mixed No bladder cuff | Regional 42.4/24.4* | pT3: 31.3/21.9* pT4: 3.9/1.5 | Low grade: 40.3/38.1 High grade: 59.7/61.9 | 7.2/2.2* | 25.9/24.1 | 21.3/14.8* | NR | Excluded | Excluded |
Fairey et al. (2013) [14] | NR | Mixed | Regional 34/25* | pT3: 25/26 pT4: 6/5 | Low grade: 31/36 High grade: 69/64 | 10/4* | 10/25 | NR | 11/10 | NR | 9/13 |
Favaretto et al. (2010) [15] | TP, RP | Mixed | Mainly regional 81/70 | pT3: 32/32 | Low grade: 12/9 High grade: 86/87 | 16/13 | 29/28 | NR | NR | NR | NR |
Fradet et al. (2014) [16] | NR | Mixed | Extent not described Selectively performed | NR | G1: 29.2/37 G2–G3: 70.8/63.0 | 11.2/4.3* | NR | NR | NR | Excluded | 7.2/12.5* |
Kido et al. (2018) [17] | RP | Open extravesical | Regional Selectively performed | pT3: 40/41 pT4: 4/0 | Low grade: 6/1 High grade: 94/99 | 7.7/4 | NR | 39/23 | 4/0* | 20/41* | 3.3/0 |
Kim SH et al.(2016) [18] | TP | Open extravesical | Regional Selectively performed | pT3/T4: 41.3/34 | Low grade: 30/35.1 High grade: 70/64.9 | 3.7/0 | 13.7/13 | 19.2/19 | 4.1/3 | Excluded | 24/20 |
Kim HS et al. (2019) [19] | TP | Open extravesical | Regional 44.5/45.6 | pT3: 40.1/38.2 pT4: 1.4/1.1 | Low grade: 27.9/31.8 High grade: 69.8/65.5 | 4.6/4.9 | 15.7/14.1 | 20.5/19.9 | NR | Excluded | 20.1/20.4 |
Kitamura et al. (2014) [20] | TP, RP | Mixed | Extent not described Selectively performed | pT3: 47/43 | G1: 3/3 G2: 41/50 G3: 56/47.3 | NR | NR | 38/22 | NR | NR | NR |
Koda et al. (2007) [21] | RP | Open extravesical | Not performed | pT3: 25.9/35.4 pT4: 0/3.8 | G1: 11.1/12.7 G2: 59.3/41.8 G3: 29.6/45.6 | NR | NR | NR | NR | NR | 14.8/12.7 |
Lee et al. (2019) [22] | TP | Mixed | Extent not described Selectively performed | pT3: 39.1/33.6 pT4: 10.6/1.5 | G1: 0.6/0.7 G2: 42.2/54 G3: 57.1/45.3 | 36.6/19.7* | NR | 41.6/25.5* | NR | NR | NR |
Lenis et al. (2018) [23] | NR | NR | Extent not described 35.1/27.4 | pT3: 35.9/34.9 pT4: 7/4.1 | Low grade: 23.4/25.6 High grade: 76.6/74.4 | 12/6.1* | NR | NR | 12.7/7.4* | 3.2/1.2 | 15/12.1 |
Moschini et al. (2020) [24] | NR | NR | Regional Selectively performed | pT3–pT4: 35/34 | Low grade: 53/60* High grade: 47/40 | 15/6* | 21/18 | 32/27 | NR | NR | 16/14 |
Shigeta et al. (2019) [25] | TP, RP | Open extravesical | Regional Selectively performed | pT3: 100/100 | Low grade: 31.9/41.7 High grade: 68.1/58.3 | 0/0 | NR | 56.9/48.6 | NR | Excluded | 38.9/29.2 |
Simone et al. (2009) [5] | TP | Laparoscopic extravesical | Not performed | pT3: 32.5/30 | Low grade: 37.5/42.5 High grade: 62.5/57.5 | 0/0 | NR | NR | NR | NR | In patients with metastases |
Taweemonkongsap et al. (2008) [26] | RP | Open extravesical | Extent not described 31/64.5 | pT3: 13.8/12.9 pT4: 0/3.2 | Low grade: 34.5/58.1 High grade: 65.5/41.9 | 10.3/3.2 | NR | NR | NR | NR | 10.3/3.2 |
Walton et al. (2011) [27] | TP | NR | Regional 23.3/30 | pT3: 27.9/27.1 pT4: 5.7/5.7 | G1: 12.4/15.7* G2: 31.2/7.1 G3: 56.3/77.1 | 6.8/2.9* | 11.1/17.1 | 18.8/22.9 | NR | Excluded | 7.7/17.1* |